Laurion Capital Management LP Astrazeneca PLC Put Options Transaction History

Laurion Capital Management LP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $1.62 Million - $4.14 Million	-30,500 Reduced 7.85%	358,000 $19.6 Million
Q2 2022 Aug 15, 2022	BUY	$59.26 - $71.14 $16.4 Million - $19.6 Million	276,000 Added 245.33%	388,500 $25.7 Million
Q1 2022 May 16, 2022	BUY	$55.72 - $67.12 $6.27 Million - $7.55 Million	112,500 New	112,500 $7.46 Million
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $6.48 Million - $7.66 Million	-120,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $6.67 Million - $7.29 Million	120,000 New	120,000 $7.21 Million

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.